Of note, TNBC can be subdivided into claudin-low BC enriched for mesenchymal and stemness markers CD44+/CD24- and basal-like TNBC characterized by stemness markers such as CD133 and MET [25]. This evidence concerns the gene CD44 and breast cancer.